4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-004973
Chief Financial Officer sold 50,000 shares at an average $67.33 ($3,366,555)
- Chief Financial Officer acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2021-01-20 | Option exercise | +50,000 | $6.32 | $316,000 | 51,000 | D: show line 1 in the form |
| Cohen Chad M Chief Financial Officer | 2021-01-20 | Sale | −11,050 | $66.82 | $738,361 | 39,950 | D: show line 2 in the form |
| Cohen Chad M Chief Financial Officer | 2021-01-20 | Sale | −33,938 | $67.35 | $2,285,724 | 6,012 | D: show line 3 in the form |
| Cohen Chad M Chief Financial Officer | 2021-01-20 | Sale | −5,012 | $68.33 | $342,470 | 1,000 | D: show line 4 in the form |
| Open-market sales · 50,000 sh · avg $67.33 · $3,366,555 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2021-01-20 | Option exercise · Stock Option (Right to Buy) | −50,000 | 265,000 | D: show line 5 in the form |
Loading xslF345X03/doc4.xml…